BivaliRudin in Acute Myocardial Infarction vs. Glycoprotein IIb/IIIa and Heparin - BRIGHT

Description:

Although bivalirudin has been shown to be superior to heparin + glycoprotein (GP) IIb/IIIa use for bleeding endpoints in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), more recent data have raised concerns for increased stent thrombosis and no significant reduction in bleeding compared with heparin monotherapy. The current trial sought to compare outcomes with three different strategies for anticoagulation for patients undergoing PCI for ACS in C...